This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1953 Jun;8(2):201-7.

doi: 10.1111/j.1476-5381.1953.tb00779.x.

Investigations on the hypotensive effect of the hydrogenated ergot alkaloids

H KONZETT, E ROTHLIN

PMID: 13066723
PMCID: PMC1509327
DOI: 10.1111/j.1476-5381.1953.tb00779.x

Investigations on the hypotensive effect of the hydrogenated ergot alkaloids

H KONZETT et al. Br J Pharmacol Chemother. 1953 Jun.

. 1953 Jun;8(2):201-7.

doi: 10.1111/j.1476-5381.1953.tb00779.x.

Authors

H KONZETT, E ROTHLIN

PMID: 13066723
PMCID: PMC1509327
DOI: 10.1111/j.1476-5381.1953.tb00779.x

No abstract available

PubMed Disclaimer

Similar articles

[Effect of hydrogenated ergot alkaloids on the orthostatic ECG with special reference to hemodynamics].
STRODER U, KOPPERMANN E. STRODER U, et al. Z Kreislaufforsch. 1952 Jan;41(1-2):21-30. Z Kreislaufforsch. 1952. PMID: 14932162 Undetermined Language. No abstract available.
[Comparative studies on the effect of natural and hydrogenated ergot alkaloids on adrenal-induced hyperglycemia].
JURNA I. JURNA I. Arch Int Pharmacodyn Ther. 1959 Nov 1;122:350-6. Arch Int Pharmacodyn Ther. 1959. PMID: 13853189 German. No abstract available.
[Effects of hydergin on the experimental gangrene of the rat tail caused by ergotamine; correlations between genuine and hydrogenated ergot alkaloids].
STUCKI P. STUCKI P. Arch Int Pharmacodyn Ther. 1952;90(2-3):159-68. Arch Int Pharmacodyn Ther. 1952. PMID: 12977394 Undetermined Language. No abstract available.
Experimental psycho-neurogenic hypertension and its treatment with hydrogenated ergot alkaloids (hydergine).
ROTHLIN E, CERLETTI A, EMMENEGGER H. ROTHLIN E, et al. Acta Med Scand Suppl. 1956;312:27-35. doi: 10.1111/j.0954-6820.1956.tb16947.x. Acta Med Scand Suppl. 1956. PMID: 13339143 No abstract available.
The hydrogenated ergot alkaloids (hydergine); a hypotensive agent.
SCHULTZ FB. SCHULTZ FB. Am Pract Dig Treat. 1953 May;4(5):330-6. Am Pract Dig Treat. 1953. PMID: 13050917 No abstract available.

See all similar articles

Cited by

Effects of phentolamine, dihydroergocristine and isoxsuprine on the blood pressure and heart rate in normotensive, hypotensive and hypertensive rats.
Morpurgo C, Faini D, Falcone A. Morpurgo C, et al. Naunyn Schmiedebergs Arch Pharmacol. 1975;290(4):335-46. doi: 10.1007/BF00499947. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 811997
Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension.
Uehlinger DE, Weidmann P, Gnaedinger MP. Uehlinger DE, et al. Eur J Clin Pharmacol. 1989;36(2):119-25. doi: 10.1007/BF00609182. Eur J Clin Pharmacol. 1989. PMID: 2721537 Clinical Trial.
VASOCONSTRICTOR ACTION OF TOLAZOLINE.
BENFEY BG, VARMA DR. BENFEY BG, et al. Br J Pharmacol Chemother. 1964 Feb;22(1):66-71. doi: 10.1111/j.1476-5381.1964.tb01544.x. Br J Pharmacol Chemother. 1964. PMID: 14126059 Free PMC article.
Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed.
Aellig WH, Berde B. Aellig WH, et al. Br J Pharmacol. 1969 Jul;36(3):561-70. doi: 10.1111/j.1476-5381.1969.tb08011.x. Br J Pharmacol. 1969. PMID: 5789809 Free PMC article.
10-Methoxyergoline derivatives as -adrenergic blocking agents.
Arcari G, Bernardi L, Bosisio G, Coda S, Fregnan GB, Glässer AH. Arcari G, et al. Experientia. 1972 Jul 15;28(7):819-20. doi: 10.1007/BF01923151. Experientia. 1972. PMID: 4144586 No abstract available.

See all "Cited by" articles

References

1. Arch Int Pharmacodyn Ther. 1950 Dec;84(2-3):393-400 - PubMed
1. J Physiol. 1951 Feb;112(3-4):273-91 - PubMed
1. Circulation. 1951 Oct;4(4):563-5 - PubMed
1. Circulation. 1950 Jun;1(6):1233-45 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources